- Resource Type:
- AATS Journals Webinars
AATS Journals Webinar Editor Roundtable: Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA NSCLC in the randomized phase III IMpower010 trial
September 25, 2024
TA D'Amico, JM Lee, B Weksler, B Sepesi, U Sachdeva , AATS Journals Webinar
Description
Editor Roundtable: Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA NSCLC in the randomized phase III IMpower010 trial
Related Articles in the AATS Journals:
Lee, Altorki, et al. “Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non–small cell lung cancer in the randomized phase III IMpower010 trial” https://doi.org/10.1016/j.jtcvs.2023.01.012 Published 2023 in JTCVS.
Rusch, Lee, et al. “Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer” https://doi.org/10.1016/j.jtcvs.2022.10.007 Published 2022 in JTCVS.
Altorki, Wakelee, et al. “Adjuvant therapy for early-stage non–small cell lung cancer: The breaking of a new dawn” https://doi.org/10.1016/j.jtcvs.2022.01.046 Published 2022 in JTCVS.